Closing the Loop
High growth market, diabetes products with exclusive supply agreements and management with a track record of success in this market.
Until a cure, Type 1 diabetes (T1D) sufferers have a life long task to self monitor and self manage their blood glucose levels 24/7, 365 days of the year. Closing The Loop (CTL) identifies, supplies and supports advanced, differentiated diabetes technologies that assists people with T1D manage their diabetes more easily. CTL's management, with a successful track record, believes a dominant position can be gained in this market.